Upgrade to SI Premium - Free Trial

Fulcrum Therapeutics Inc. (FULC)

3.79 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Form 425 Fulcrum Therapeutics, Filed by: Fulcrum Therapeutics, Inc. August 17, 2026 4:24 PM - SEC Filing Form 425 Fulcrum Therapeutics, Filed by: Fulcrum Therapeutics, Inc. August 17, 2026 8:33 AM - SEC Filing Form 425 Fulcrum Therapeutics, Filed by: Fulcrum Therapeutics, Inc. August 17, 2026 8:32 AM - SEC Filing Form 8-K Fulcrum Therapeutics, For: Aug 16 August 17, 2026 8:30 AM - SEC Filing Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal August 17, 2026 7:01 AM - StreetInsider Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies August 17, 2026 7:00 AM - StreetInsider Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. August 14, 2026 4:50 PM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: Nantahala Capital Management, LLC August 14, 2026 4:47 PM - SEC Filing Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: MONTANOVA CAPITAL, LLC August 14, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: TCG Crossover GP II, LLC August 14, 2026 4:30 PM - SEC Filing Form 8-K Fulcrum Therapeutics, For: Aug 07 August 10, 2026 8:44 AM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: BANK OF AMERICA CORP /DE/ August 3, 2026 12:13 PM - SEC Filing Form 10-Q Fulcrum Therapeutics, For: Jun 30 July 30, 2026 4:06 PM - SEC Filing Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: BlackRock, Inc. July 28, 2026 4:47 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jul 16 Filed by: TANG KEVIN July 20, 2026 9:10 PM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: BlackRock Portfolio Management LLC July 17, 2026 11:34 AM - SEC Filing Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC July 15, 2026 7:54 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jul 13 Filed by: TANG KEVIN July 15, 2026 7:50 PM - SEC Filing Form 3 Fulcrum Therapeutics, For: Jul 13 Filed by: TANG KEVIN July 15, 2026 7:49 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Banks Sonja July 2, 2026 4:32 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Dorton Katina July 2, 2026 4:31 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Gould Robert J July 2, 2026 4:31 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Haviland Kate July 2, 2026 4:31 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: GERAGHTY JAMES A July 2, 2026 4:30 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Ezekowitz Alan July 2, 2026 4:30 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: King Rachel K. July 2, 2026 4:30 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Hill Colin July 2, 2026 4:30 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 26 Filed by: Ezekowitz Alan June 30, 2026 4:30 PM - SEC Filing Form 144 Fulcrum Therapeutics, Filed by: Ezekowitz Alan June 26, 2026 4:27 PM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: EcoR1 Capital, LLC June 25, 2026 6:11 PM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: EcoR1 Capital, LLC June 25, 2026 5:51 PM - SEC Filing Form 8-K Fulcrum Therapeutics, For: Jun 24 June 25, 2026 4:32 PM - SEC Filing Full Article List